Finally, Anti-Ageing Drugs Might Be A Thing
Life | November 22, 2016
For years, people have been trying to find new ways to slow down the ageing process. Some even try to just expand our lifespan. Is it really possible though? Well, with the experiments we have on mice, it’s definitely a possibility. However, it has yet to be tested on humans. The product is a compound called nicotinamide monoucleotide, aka NMN.
There is good news, though. NMN is about to undergo human test trials for the very first time and this could be the first step to getting it cleared for public use. In about a month, this compound will be given to 10 people. They will be testing to see if it actually slows down the normal ageing process, but also whether or not it does it with any harmful effects.
If the experiment goes well and receives positive results, then it could be cleared for public use. If that happens, it will be the first actually clinically tested anti-ageing product to ever hit shelves.
Part of what this compound is doing is stimulating the production of a certain type of protein that tends to get weaker the older humans get. That protein is sirtuin and could be the reason we see our body deplete over time.
With testing on mice already done, they have shown that the mice tend to keep their metabolism, their eyesight and glucose intolerance. Those are three things that tend to decline the older we get. However, just because it works on mice doesn’t mean it will work on humans.
It’s a good start, though. Mice are very similar to humans, in the fact that they share roughly 95-98 percent of a human’s genomes. In addition, they also come down with many of the same diseases that humans do. There’s just never a sure sign when testing on mice, regarding whether it will have the same effect on a human. With that being said, we will just have to be patient and wait for the testing on humans to come to a finish.
For those of you wondering, these tests that I am speaking of will be held in Japan and will be controlled by Keio University and Washington University in St. Louis. Although it might not be as big of an issue in the US, it’s a rather hot topic in Japan due to their population being mostly elders. In the year 2055, nearly 40 percent of Japan’s population will be over the age of 65.
Shin-ichiro, who is the lead researcher of the study, commented on the mission to The Japan News. “We’ve confirmed a remarkable effect in the experiment using mice, but it’s not clear yet how much [the compound] will affect humans,” said Shin-ichiro. “We’ll carefully conduct the study, which I hope will result in important findings originating in Japan,” he continued.
It seems as though massive leaps are being made in the anti-ageing industry. It seems that we could be on the verge of having a solution soon. It’s about time!